226 related articles for article (PubMed ID: 24599325)
1. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy.
Clark JT; Clark MR; Shelke NB; Johnson TJ; Smith EM; Andreasen AK; Nebeker JS; Fabian J; Friend DR; Kiser PF
PLoS One; 2014; 9(3):e88509. PubMed ID: 24599325
[TBL] [Abstract][Full Text] [Related]
2. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM
J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920
[TBL] [Abstract][Full Text] [Related]
3. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.
Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK
Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275
[TBL] [Abstract][Full Text] [Related]
4. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.
Gupta KM; Pearce SM; Poursaid AE; Aliyar HA; Tresco PA; Mitchnik MA; Kiser PF
J Pharm Sci; 2008 Oct; 97(10):4228-39. PubMed ID: 18338805
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
Thurman AR; Schwartz JL; Brache V; Clark MR; McCormick T; Chandra N; Marzinke MA; Stanczyk FZ; Dezzutti CS; Hillier SL; Herold BC; Fichorova R; Asin SN; Rollenhagen C; Weiner D; Kiser P; Doncel GF
PLoS One; 2018; 13(6):e0199778. PubMed ID: 29953547
[TBL] [Abstract][Full Text] [Related]
6. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir.
Johnson TJ; Gupta KM; Fabian J; Albright TH; Kiser PF
Eur J Pharm Sci; 2010 Feb; 39(4):203-12. PubMed ID: 19958831
[TBL] [Abstract][Full Text] [Related]
7. Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate.
Simpson SM; Widanapathirana L; Su JT; Sung S; Watrous D; Qiu J; Pearson E; Evanoff A; Karunakaran D; Chacon JE; Kiser PF
Pharm Res; 2020 Apr; 37(4):83. PubMed ID: 32296951
[TBL] [Abstract][Full Text] [Related]
8. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.
Johnson TJ; Clark MR; Albright TH; Nebeker JS; Tuitupou AL; Clark JT; Fabian J; McCabe RT; Chandra N; Doncel GF; Friend DR; Kiser PF
Antimicrob Agents Chemother; 2012 Dec; 56(12):6272-83. PubMed ID: 23006751
[TBL] [Abstract][Full Text] [Related]
9. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
Thurman AR; Schwartz JL; Ravel J; Gajer P; Marzinke MA; Yousefieh N; Anderson SM; Doncel GF
PLoS One; 2019; 14(5):e0217229. PubMed ID: 31107913
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of an HIV prophylactic and contraceptive using PGSU as a long-acting multipurpose prevention technology.
Cohen J; Shull D; Reed S
Expert Opin Drug Deliv; 2023 Feb; 20(2):285-299. PubMed ID: 36654482
[TBL] [Abstract][Full Text] [Related]
11. Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device.
Murphy DJ; Boyd P; McCoy CF; Kumar S; Holt JD; Blanda W; Brimer AN; Malcolm RK
J Control Release; 2016 Mar; 226():138-47. PubMed ID: 26878974
[TBL] [Abstract][Full Text] [Related]
12. Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.
Chen Y; Traore YL; Li A; Fowke KR; Ho EA
Drug Des Devel Ther; 2014; 8():1801-15. PubMed ID: 25336923
[TBL] [Abstract][Full Text] [Related]
13. Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology.
McConville C; Major I; Devlin B; Brimer A
Eur J Pharm Biopharm; 2016 Jul; 104():171-9. PubMed ID: 27163243
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir.
Clark JT; Johnson TJ; Clark MR; Nebeker JS; Fabian J; Tuitupou AL; Ponnapalli S; Smith EM; Friend DR; Kiser PF
J Control Release; 2012 Oct; 163(2):240-8. PubMed ID: 22981701
[TBL] [Abstract][Full Text] [Related]
15. A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo.
Villegas G; Calenda G; Ugaonkar S; Zhang S; Kizima L; Mizenina O; Gettie A; Blanchard J; Cooney ML; Robbiani M; Fernández-Romero JA; Zydowsky TM; Teleshova N
PLoS One; 2016; 11(7):e0159332. PubMed ID: 27428377
[TBL] [Abstract][Full Text] [Related]
16. Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings.
Johnson TJ; Srinivasan P; Albright TH; Watson-Buckheit K; Rabe L; Martin A; Pau CP; Hendry RM; Otten R; McNicholl J; Buckheit R; Smith J; Kiser PF
Antimicrob Agents Chemother; 2012 Mar; 56(3):1291-9. PubMed ID: 22155820
[TBL] [Abstract][Full Text] [Related]
17. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
Smith JM; Moss JA; Srinivasan P; Butkyavichene I; Gunawardana M; Fanter R; Miller CS; Sanchez D; Yang F; Ellis S; Zhang J; Marzinke MA; Hendrix CW; Kapoor A; Baum MM
PLoS One; 2017; 12(10):e0185946. PubMed ID: 28982161
[TBL] [Abstract][Full Text] [Related]
18. Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures.
Blakney AK; Krogstad EA; Jiang YH; Woodrow KA
Int J Nanomedicine; 2014; 9():2967-78. PubMed ID: 24971008
[TBL] [Abstract][Full Text] [Related]
19. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812
[TBL] [Abstract][Full Text] [Related]
20. An intravaginal ring for the simultaneous delivery of multiple drugs.
Baum MM; Butkyavichene I; Gilman J; Kennedy S; Kopin E; Malone AM; Nguyen C; Smith TJ; Friend DR; Clark MR; Moss JA
J Pharm Sci; 2012 Aug; 101(8):2833-43. PubMed ID: 22619076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
